Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 1

Status

Completed 9Recruiting 3Withdrawn 1Terminated 1Active not recruiting 1

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 2Breast 1

Conditions

Pancreatic Neoplasms 56Biliary Tract Neoplasms 24Cholangiocarcinoma 23Nasopharyngeal Carcinoma 22Carcinoma, Non-Small-Cell Lung 22Urinary Bladder Neoplasms 18Breast Neoplasms 18Neoplasm Metastasis 17Lung Neoplasms 14Lymphoma, Large B-Cell, Diffuse 13Colorectal Neoplasms 12Carcinoma, Transitional Cell 12Recurrence 9Non-Muscle Invasive Bladder Neoplasms 9Sarcoma 8Ovarian Neoplasms 8Triple Negative Breast Neoplasms 7Neoplasms 7Gallbladder Neoplasms 7Hodgkin Disease 6Nasopharyngeal Neoplasms 5Bile Duct Neoplasms 5Adenocarcinoma 5Uterine Cervical Neoplasms 4Locally Advanced Pancreatic Cancer 4Endometrial Neoplasms 4Parkinson Disease 4, Autosomal Dominant Lewy Body 3Pancreatic Adenocarcinoma 3Osteosarcoma 3Lymphoma, T-Cell, Peripheral 3

Interventions

pembrolizumab 19Paclitaxel 13Carboplatin 10Pemetrexed 4Cisplatin 4patritumab deruxtecan 3Gemcitabine 3Docetaxel 3Capecitabine 3Albumin-Bound Paclitaxel 3Histamine H2 Antagonists 2Histamine Antagonists 2Dexamethasone 2Acetaminophen 2130-nm albumin-bound paclitaxel 2trastuzumab deruxtecan 1osimertinib 1olaparib 1liposomal doxorubicin 1lenvatinib 1enzalutamide 1cemiplimab 1Vascular Endothelial Growth Factor A 1Serotonin 5-HT3 Receptor Antagonists 1Ramucirumab 1Oxaliplatin 1Neurokinin-1 Receptor Antagonists 1Neoadjuvant Therapy 1Levoleucovorin 1Leucovorin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × Parkinson Disease 4, Autosomal Dominant Lewy Body × Gemcitabine × Clear all
NCT06788912 2026-05-26

MK-3475-01E

Merck Sharp & Dohme LLC

Phase 2 Recruiting
60 enrolled
Thoracic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Lung Neoplasms

NCT06841354 2026-05-22

TroFuse-011

Merck Sharp & Dohme LLC

Phase 3 Recruiting
1,000 enrolled
Breast

Parkinson Disease 4, Autosomal Dominant Lewy Body, Triple Negative Breast Neoplasms

NCT06623422 2026-05-15

INTerpath-009

Merck Sharp & Dohme LLC

Phase 3 Recruiting
680 enrolled
Thoracic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡